Triage Survey for Infectious Disease Eligibility
NCT06492187
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
SWIFT-ID-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials for diagnosis, treatment, or prevention of infectious diseases such as in the areas of HIV, vaccines, and other infectious-diseases areas. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical/surgical history, physical examination, comorbidities, and any current symptoms. Informed consent will be done electronically (preferable) or on paper.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Vaccination; Infection
- HIV-1-infection
- Infectious Disease
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Brooklyn Clinical Research
- Last updated on ClinicalTrials.gov
- July 9, 2024
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 1
- Brooklyn Clinical Research · Brooklyn, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.